SCHEMBL4167758

SCHEMBL4167758

Clc1ccccc1C(Cl)Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
HIF1A Q16665 3/20 0.47
LMNA P02545 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 2/20 0.47
BLM P54132 2/20 0.47
CYP2C9 P11712 1/20 0.47
KDM4E B2RXH2 1/20 0.47
NR1I2 O75469 1/20 0.47
ABCB11 O95342 1/20 0.47
NR3C1 P04150 1/20 0.47
PGR P06401 1/20 0.47
ADRA2A P08913 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
MAPT P10636 1/20 0.47
CNR1 P21554 1/20 0.47
SLC6A2 P23975 1/20 0.47
ACAT1 P24752 1/20 0.47
MAPK1 P28482 1/20 0.47
SLC6A4 P31645 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4815784 0.81 TSHR (0.47) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL9677445 0.81 TSHR (0.47) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL30848757 0.78 TSHR (0.50) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL947512 0.78 TSHR (0.50) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL11617245 0.78 TSHR (0.50) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL320794 0.77 P2RX7 (0.47) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL13145151 0.77 P2RX7 (0.47) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL5627145 0.77 TSHR (0.43) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL9503376 0.77 ADRB2 (0.46) TSHRHIF1ALMNACYP2C19CYP3A4
SCHEMBL8651062 0.76 TSHR (0.47) TSHRHIF1ALMNACYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115784972-A Ethylene diamine derivative and preparation method and application thereof 江苏普莱医药生物技术有限公司 2023-03-14 CN claimed
EP-1773934-A2 NOVEL FIRE RETARDANTS Bromine Compounds Ltd. (IL) 2007-04-18 EP claimed
WO-2006006154-A2 NOVEL FIRE RETARDANTS BROMINE COMPOUNDS LTD. (IL) 2006-01-19 WO claimed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 CN disclosed
CN-114181207-B Beta-carboline compounds, preparation method thereof and application thereof in resisting Alzheimer disease 中国人民解放军北部战区总医院 2022-12-13 CN disclosed
CN-114975904-A Polyoxometalate-based viologen polymer derived carbide composite material and preparation method and application thereof 上海应用技术大学 2022-08-30 CN disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 WO disclosed
CN-109111463-A The manufacturing method of aromatic compound DIC株式会社 2019-01-01 CN disclosed
CN-103214471-B The preparation method of compound with Na-dependent glucose transporter inhibitory activity 田边三菱制药株式会社 2018-02-06 CN disclosed
WO-2009033689-A1 PIPERIDONE DERIVATIVES AND MEDICAL USES THEREOF HEINRICH-PETTE-INSTITUT (DE) 2009-03-19 WO disclosed
EP-2036556-A1 Piperidone derivatives and medical uses thereof Heinrich-Pette-Institut (DE) 2009-03-18 EP disclosed
US-6140344-A FOR TREATING PATHOLOGICAL CONDITIONS SUCH AS ASTHMA, RHINITIS, ECZEMA AND PARASITIC INFECTIONS FEATURING TISSUE EOSINOPHILIA SYNTEX (U.S.A.) INC. (US) 2000-10-31 US disclosed
US-6093696-A N-ACETYL-D-THIOPROLINE-(O-2,6-DICHLOROBENZYL)-L-TYROSINE, FOR EXAMPLE; SELECTIVELY INHIBIT THE ALPHA 4 SUBGROUP OF INTEGRINS FROM BINDING TO THEIR LIGANDS; USE IN PROPHYLAXIS OR TREATMENT OF IMMUNE OR INFLAMMATORY DISEASES CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 US disclosed
WO-2000031033-A1 PIPERIDINE CCR-3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-02 WO disclosed
WO-2000029377-A1 4-AROYL-PIPERIDIN-CCR-3 RECEPTOR ANTAGONISTS III F. HOFFMANN-LA ROCHE AG (CH) 2000-05-25 WO disclosed
EP-0984981-A1 ANTI-INFLAMMATORY TYROSINE DERIVATIVES CELLTECH THERAPEUTICS LIMITED (GB) 2000-03-15 EP disclosed
EP-0903349-A2 CCR-3 receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1999-03-24 EP disclosed
WO-1998054207-A1 ANTI-INFLAMMATORY TYROSINE DERIVATIVES CELLTECH THERAPEUTICS LIMITED (GB) 1998-12-03 WO disclosed
US-5234917-A Hypotensive agent, treatment of renal failure or glaucoma SMITHKLINE BEECHAM CORPORATION 1993-08-10 US disclosed
EP-0220810-A1 Insecticidal ethers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-05-06 EP disclosed